Table 2.
BCVA at final visit in HSV, HZV, CMV keratouveitis
BCVA (in LogMAR) | HSV | HZV | CMV | Total | p-value |
---|---|---|---|---|---|
20/20 - 20/40 (0-0.3) | 18 | 5 | 2 | 25 | 0.774 |
20/50 - 20/200 (0.4-1) | 19 | 3 | 22 | ||
CF-PL (1.3-2.5) | 6 | 1 | 7 | ||
NPL4 | 1 | 1 | |||
Total | 44 | 9 | 2 | 55 |
BCVA at final visit in HSV, HZV, CMV keratouveitis
BCVA (in LogMAR) | HSV | HZV | CMV | Total | p-value |
---|---|---|---|---|---|
20/20 - 20/40 (0-0.3) | 18 | 5 | 2 | 25 | 0.774 |
20/50 - 20/200 (0.4-1) | 19 | 3 | 22 | ||
CF-PL (1.3-2.5) | 6 | 1 | 7 | ||
NPL4 | 1 | 1 | |||
Total | 44 | 9 | 2 | 55 |